Retail investors are in the market to stay, and they have more access, tools and information than ever before – but the industry still needs to provide the expertise and oversight to assure a good ...

A plot of land in western Spain seemed like the perfect place for a solar plant. Flat terrain. Wide open spaces. No obvious obstacles. But as crews began clearing the area, buried deep beneath the ...

Keeping tabs on blood sugar throughout the day used to be the exclusive domain of people with diabetes. But in 2026, anyone can buy a user-friendly wearable device that provides minute-by-minute ...

Shares of Credo Technology were soaring on Tuesday morning following an acquisition that will help it capture more share of the hot market for optical connectivity. Credo CRDO announced on Monday that ...

It's time to get those brackets filled out. In just three days, the Men's NCAA Tournament will officially get underway with No. 8 Ohio State vs. No. 9 TCU in Greenville at 12:15 p.m. ET, the first of ...

Casdin Capital sold 380,000 shares of Structure Therapeutics in the fourth quarter for an estimated $15.52 million. Meanwhile, the quarter-end position value actually increased by $38.18 million, ...

Discover the single largest continuous structure ever made by humans. American manufacturer’s hidden tag calling president "idiot" resurfaces The far-fetched mission to reclaim islands that host a key ...

More than 15 years ago, on behalf of an internationally recognized financial services firm, Goodwin created the first open-ended non-traded REIT structure that allowed for regular sales and ...

The U.S. Senate Banking Committee will not have any markup hearings on market structure legislation defining how federal regulators can oversee the industry until next year, punting on a hoped-for ...

Forty years ago, “Back to the Future” premiered in theaters. The movie, about a teenager who inadvertently travels back in time, grossed around $222 million worldwide in inflation-adjusted dollars. If ...

Treatment of chronic lymphocytic leukemia (CLL) currently consists of two main approaches — continuous therapy with Bruton’s tyrosine kinase inhibitors and fixed-duration regimens combining venetoclax ...